Glucosylceramide synthase and apoptosis

被引:119
作者
Bleicher, RJ [1 ]
Cabot, MC [1 ]
机构
[1] St Johns Hlth Ctr, John Wayne Canc Inst, Breast Canc Program, Santa Monica, CA 90403 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2002年 / 1585卷 / 2-3期
关键词
glucosylceramide synthase; glucosylceramide; apoptosis; ceramide; drug resistance;
D O I
10.1016/S1388-1981(02)00338-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucosylceramide synthase (GCS) is an enzyme inherent to ceramide metabolism. The enzyme catalyzes the transfer of glucose to ceramide, the first committed step in glycolipid biosynthesis. Known for many years as a branch point enzyme directing synthesis of cerebrosides and gangliosides, GCS has recently been implicated in the cytotoxic response of cancer cells to chemotherapy. With ceramide now occupying a central role in the signaling mechanisms of apoptosis, the position of GCS as sentry is perhaps not unexpected. In particular, it has been recognized that the toxic response of cells to chemotherapy is impaired when GCS activity is elevated and heightened when GCS activity is blocked. Herein we review the control points of ceramide metabolism with special regard to GCS and the cytotoxic response. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:172 / 178
页数:7
相关论文
共 65 条
[1]   Induction of glucosylceramide synthase by synthase inhibitors and ceramide [J].
Abe, A ;
Radin, NS ;
Shayman, JA .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (03) :333-341
[2]   DIFFERENTIAL METABOLISM AND TRAFFICKING OF SPHINGOLIPIDS IN DIFFERENTIATED VERSUS UNDIFFERENTIATED HT29 CELLS [J].
BABIA, T ;
KOK, JW ;
HULSTAERT, C ;
DEWEERD, H ;
HOEKSTRA, D .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (05) :839-845
[3]  
BALLOU LR, 1992, J BIOL CHEM, V267, P20044
[4]  
BASU S, 1968, J BIOL CHEM, V243, P5802
[5]   Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells [J].
Biswal, SS ;
Datta, K ;
Acquaah-Mensah, GK ;
Kehrer, JP .
TOXICOLOGY, 2000, 154 (1-3) :45-53
[6]   Tamoxifen retards glycosphingolipid metabolism in human cancer cells [J].
Cabot, MC ;
Giuliano, AE ;
Volner, A ;
Han, TY .
FEBS LETTERS, 1996, 394 (02) :129-131
[7]   The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation [J].
Cabot, MC ;
Han, TY ;
Giuliano, AE .
FEBS LETTERS, 1998, 431 (02) :185-188
[8]   Ceramide formation during heat shock: A potential mediator of alpha B-crystallin transcription [J].
Chang, Y ;
Abe, A ;
Shayman, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) :12275-12279
[9]   Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway [J].
Deguchi, H ;
Fernández, JA ;
Pabinger, I ;
Heit, JA ;
Griffin, JH .
BLOOD, 2001, 97 (07) :1907-1914
[10]   Molecular cloning and characterization of a human mitochondrial ceramidase [J].
El Bawab, S ;
Roddy, P ;
Qian, T ;
Bielawska, A ;
Lemasters, JJ ;
Hannun, YA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (28) :21508-21513